Cochlear NMDA receptors and tinnitus

REFERENCES

• See G. Etudes sur l’acide salicylique et les salicylates; traitement du rhumatisme aigu et chronique et de la goutte, et de diverses affections du systeme nerveux sensitif par les salicylates. Bulletin de l’Academie Nationale de Medecine (Paris) 1877; 26: 689–706.
   Google Scholar
• Jastreboff PJ, Brennan JF, Coleman JK, Sasaki CT. Phantom auditory sensation in rats: an animal model for tinnitus. Behav Neurosci 1988; 102: 811–22.
   PubMed Web of Science ®Google Scholar
• Jastreboff PJ, Sasaki CT. An animal model of tinnitus: a decade of development. Am J Otol 1988; 15: 19–27.
   Google Scholar
• Guitton MJ, Caston J, Ruel J, JohnsonRM, Pujol R, Puel JL. Salicylate induces tinnitus through activation of cochlear NMDA receptors. J Neurosci 2003; 23: 3944–52.
   PubMed Web of Science ®Google Scholar
• Cazals Y. Auditory sensorineural alterations induced by salicylate. Prog Neurobiol 2000; 62: 583–631.
   PubMed Web of Science ®Google Scholar
• Kakehata S, Santos-Sacchi J. Effects of salicylate and lanthanides on outer hair cell motility and associated gating charge. J Neurosci 1996; 16: 4881–9.
   PubMed Web of Science ®Google Scholar
• Zheng J, Shen W, He DZ, Long KB, Madison LD, Dallos P. Prestin is the motor protein of cochlear outer hair cells. Nature 2000; 405: 149–55.
   PubMed Web of Science ®Google Scholar
• Evans EF, Borerwe TA. Ototoxic effects of salicylates on the responses of single cochlear nerve fibres and on cochlear potentials. Br JAudiol 1982; 16: 101–8.
   PubMedGoogle Scholar
• Stypulkowski PH. Mechanisms of salicylate ototoxicity. Hear Res 1990; 46: 113—46.
   PubMed Web of Science ®Google Scholar
• Cazals Y, Horner KC, Huang ZW. Alterations in average spectrum of cochleoneural activity by long-term salicylate treatment in the guinea pig: a plausible index of tinnitus. J Neurophysiol 1998; 80: 2113–20.
   PubMed Web of Science ®Google Scholar
• Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 1971; 231: 232–5.
   Web of Science ®Google Scholar
• Levy GN. Prostaglandin H synthases, non-steroidal antiinflammatory drugs, and colon cancer. FASEB J 1997; 11: 234—47.
   PubMed Web of Science ®Google Scholar
• Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998; 38: 97–120.
   PubMed Web of Science ®Google Scholar
• Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, Vane JR. Selectivity of non-steroidal anti-inflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 1993; 90: 11693–7.
   PubMed Web of Science ®Google Scholar
• Vane JR, Botting RM. Mechanism of action of non-steroidal anti-inflammatory drugs. Am J Med 1998; 104: 2S-8S.
   Google Scholar
• Thiemermann C. Biosynthesis and interaction of endothe-lium-derived vasoactive mediators. Eicosanoids 1991; 4: 187–202.
   PubMedGoogle Scholar
• Escoubet B, Amsallen P, Ferrary E, Tran Ba Huy P. Prostaglandin synthesis by the cochlea of the guinea pig: influence of aspirin, gentamicin, and acoustic stimulation. Prostaglandins 1985; 29: 589–99.
   Google Scholar
• Jung TTK, Juhn SK. Prostaglandins in the perilymph. Ass Res Otolaryngology Abs 1984; 107.
   Google Scholar
• Jung TT, Miller SK, Rozehnal S, Woo HY, Park YM, Baer W. Effect of round window membrane application of salicylate and indomethacin on hearing and levels of arachi-donic acid metabolites in perilymph. Acta Otolaryngol Suppl 1992; 493: 81—7.
   PubMedGoogle Scholar
• Miller B, Sarantis M, Traynelis SF, Attwell D. Potentiation of NMDA receptor currents by arachidonic acid. Nature 1992; 355: 722—5.
   PubMed Web of Science ®Google Scholar
• Horimoto N, Nabekura J, Ogawa T. Developmental changes in arachidonic acid potentiation of NMDA currents in cortical neurons. NeuroReport 1996; 7: 2463—7.
   PubMedGoogle Scholar
• Yamakura T, Shimoji K. Subunit-and site-specific pharmacology of the NMDA receptor channel. Prog Neurobiol 1999; 59: 279—98.
   PubMed Web of Science ®Google Scholar
• Casado M, Ascher P. Opposite modulation of NMDA receptors by lysophospolipids and arachidonic acid: common features with mechanosensitivity. J Physiol (Lond) 1998; 513: 317—30.
   Google Scholar
• Ruel J, Chen C, Pujol R, Bobbin RP, Puel J-L. Ampa-preferring glutamate receptors in cochlear physiology of adult guinea pig. J Physiol (Lond) 1999; 518: 667—80.
   Google Scholar
• Usami S, Matsubara A, Fujita S, Shinkawa H, Hayashi M. NMDA (NMDAR1) and AMPA-type (GluR2/3) receptor subunits are expressed in the inner ear. NeuroReport 1995; 6: 1161—4.
   PubMedGoogle Scholar
• Niedzielski AS, Wenthold RJ. Expression of AMPA, kainate, and NMDA receptor subunits in cochlear and vestibular ganglia. J Neurosci 1995; 15: 2338—53.
   PubMed Web of Science ®Google Scholar
• d’Aldin CG, Ruel J, Assie R, Pujol R, Puel JL. Implication of NMDA type glutamate receptors in neural regeneration and neoformation of synapses after excitotoxic injury in the guinea pig cochlea. Int JDevNeurosci 1997; 15: 619–29.
   Google Scholar
• Basile AS, Huang JM, Xie C, Webster D, Berlin C, Skolnick P. N-methyl-D-aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss. Nat Med 1996; 2: 1338—43.
   PubMed Web of Science ®Google Scholar
• Puel J-L, Pujol R, Tribillac F, Ladrech S, Eybalin M. Excitatory amino acid antagonists protect cochlear auditory neurons from excitotoxicity. J Comp Neurol 1994; 341: 241–56.
   PubMed Web of Science ®Google Scholar
• Puel J-L. Chemical synaptic transmission in the cochlea. Prog Neurobiol 1995; 47: 449–76.
   PubMed Web of Science ®Google Scholar
• Duan M, Agerman K, Ernfirs P, Canlon B. Complementary roles of neurotrophin 3 and a N-methyl-D-aspartate antagonist in the protection of noise and aminoglycoside-induced ototoxicity. Proc Natl Acad Sci USA 2000; 97: 7597–602.
   PubMed Web of Science ®Google Scholar